Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

SHENZHEN, China, Oct. 22 Mindray MedicalInternational Limited (NYSE: MR), a leading developer, manufacturer andmarketer of medical devices worldwide today announced that it will report itsfinancial results for the third quarter ended September 30, 2008, after theU.S. market closes on November 10, 2008. Mindray's management will hold anearnings conference call at 8:00 a.m. on November 11, 2008 U.S. Eastern Time(9:00 p.m. on November 11, 2008 Beijing/Hong Kong Time) to discuss resultswith investors.

A replay of the conference call may be accessed by phone at the followingnumbers until November 22, 2008.

Additionally, a live and archived webcast of this conference call will beavailable on the Investor Relations section of Mindray's website athttp://www.mindray.com .

About Mindray

Mindray is a leading developer, manufacturer and marketer of medicaldevices worldwide. Established in 1991, Mindray offers a broad range ofproducts across three primary business segments: patient monitoring & lifesupport products, in-vitro diagnostic products and medical imaging systems.Mindray is globally headquartered in Shenzhen, China, with U.S. headquartersin Mahwah, New Jersey. Mindray also has another 12 international sales andservice offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow,Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.For more information, please visit http://www.mindray.com .Dial-in details for the earnings conference call are as follows: Hong Kong: +852-3002-1672 U.S. Toll Free: +1-866-356-3093 International: +1-617-597-5381 Passcode for all regions: Mindray

SOURCE Mindray Medical International Limited

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...